05.06.2013 Views

WPW - Dr Reyes.pdf - Socacorr

WPW - Dr Reyes.pdf - Socacorr

WPW - Dr Reyes.pdf - Socacorr

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Programa de Formación Continua 2010<br />

Sociedad de Cardiología de Corrientes<br />

Louis Wolff; John Parkinson y Paul D. White<br />

Wolf L, Parkinson J, White PD. Bundle-branch block with<br />

short P-R interval in healthy young people prone to<br />

paroxysmal tachycardia. Am Heart J. 1930;5:685-704.


Síndrome de Wolf Parkinson White


Lat dcha.<br />

Ant dcha.<br />

Ant. sept<br />

Ant. Izq.<br />

T M<br />

Post sept<br />

Seno Coron<br />

Post-lat<br />

Lat. Izq.


Wolff Parkinson White: Epidemiología<br />

N° de casos por 1000<br />

2.5<br />

2<br />

1.5<br />

1<br />

0.5<br />

0<br />

Prevalencia de <strong>WPW</strong> manifiesto<br />

(N° = 270/226464)<br />

20-29 30-39 40-49 50-59 >60<br />

Edades (años)<br />

Hombres<br />

Mujeres<br />

Soria R et al. L’histoire naturelle de 270 cas de syndrome de<br />

<strong>WPW</strong> dans une enquete de population générale. Arch Mal Coeur 1989;82:331


Wolff Parkinson White: Epidemiología<br />

En un porcentaje significativo de casos de RN con<br />

síndrome de <strong>WPW</strong>, la preexitación desaparece<br />

en el 1er. año de vida.<br />

Riesgo de MS es del 0.6 – 1.5 %.<br />

25% de las MS ocurren como primera manifestación<br />

del síndrome.<br />

En jóvenes: 3.6 % de las MS<br />

40% 1 ra. manifestación<br />

Swiderski J. The <strong>WPW</strong>syndrome in infancy and childhood. Br Heart J. 1962;24:561<br />

Giardina ACV. <strong>WPW</strong> syndrome in infant and children. Br Heart J. 1972;34:839<br />

Soria R et al. L’histoire naturelle de 270 cas de syndrome de<br />

<strong>WPW</strong> dans une enquete de population générale. Arch Mal Coeur 1989;82:331<br />

Basso C.Ventricular preexitation in children and young adults. Atrial<br />

myocarditis as a possible trigger of sudden death. Circulation 2001;103:269


Síndrome de Wolf Parkinson White<br />

LI


Sinusal<br />

“Pacing”<br />

S<br />

auricular<br />

Éxito (RF)<br />

W<br />

P<br />

W<br />

1470


ECG 12 D:<br />

<strong>WPW</strong><br />

Intermitente<br />

PSD


BCRIHH<br />

SI NO<br />

ASD<br />

Q O DELTA ISOELECTRICA EN D1,AVL O V6<br />

SI NO<br />

LI<br />

RS Rs V1-3<br />

SI<br />

SI NO<br />

PS<br />

LD<br />

EJE QRS >+30ª<br />

SI NO<br />

ASD<br />

Q EN 2 DER CARA INF<br />

NO<br />

BCRIHH<br />

SI NO<br />

LD LI<br />

RS V1-2<br />

SI NO<br />

IND


Wolff<br />

Onda δ<br />

“BRD”<br />

Parkinson White:<br />

Localización<br />

DII DIII aVf<br />

Posterior<br />

V1 “BRD”<br />

Izquierda Derecha<br />

V1<br />

Onda δ<br />

Lateral izq.<br />

DI aVl


ECG 12 D:<br />

<strong>WPW</strong><br />

PSI


ECG 12 D:<br />

<strong>WPW</strong><br />

LI


PSD


ECG 12 D:<br />

<strong>WPW</strong><br />

ALD<br />

G. A. 25 años.<br />

1468


Taquicardia<br />

por Reentrada<br />

Aurículo<br />

ventricular<br />

( TRAV )


K<br />

REENTRADA A-V<br />

AURICULA<br />

VENTRICULO<br />

N A-V<br />

HIS


REENTRADA<br />

A-V<br />

“Vía lenta”<br />

QRS<br />

P<br />

“Vía rápida”


Taquicardia por reentrada AV<br />

A<br />

NAV<br />

V<br />

QRS<br />

P’


Reentrada:<br />

• Disociac.<br />

• Bloqueo Unid<br />

• Conducción lenta


Sinus vs. TRAV<br />

1470<br />

R<br />

L<br />

F


RP 0.08 seg. TRAV<br />

< 0.08 seg TRN


<strong>WPW</strong><br />

y<br />

Fibrilación auricular


ALETEO--TAQ. AURICULAR<br />

KK<br />

PERIODO<br />

REFRACT.<br />

FIBRILACION AURICULAR<br />

VENTRICULO<br />

N-AV


<strong>WPW</strong><br />

Ablación con RF


AD<br />

His<br />

SCD<br />

RF


AD<br />

His<br />

SCP<br />

SCD<br />

RF


AD<br />

A<br />

A<br />

A<br />

3<br />

T<br />

M<br />

2<br />

1


Pre RF RF. Exito Post RF<br />

A<br />

V<br />

SI NO<br />

A<br />

V


Wolff Parkinson White: Estratificación de riesgo<br />

Período refractario anterógrado<br />

< 250 mseg.<br />

Intervalo RR preexitado<br />

< 250 mseg en FA<br />

TPSV y Fibrilación Auricular<br />

Haces múltiples<br />

“Alto riesgo” “Bajo riesgo”<br />

Anomalía de Ebstein<br />

Preexitación intermitente.<br />

Klein GJ, Gulamhusein SS. Intermittent preexcitation in the Wolff-Parkinson-White syndrome.<br />

Am J Cardiol. 1983;52:292–296<br />

Bloqueo de la vía anómala<br />

durante test ergométrico<br />

Gaita F, Giustetto C, Riccardi R, Mangiardi L, Brusca A. Stress and pharmacologic tests as methods to identify<br />

patients with Wolff-Parkinson-White syndrome at risk of sudden death. Am J Cardiol. 1989;64:487–490<br />

Sharma AD, Yee R, Guiraudon G, Klein GJ. Sensitivity and specificity of invasive and noninvasive testing for<br />

risk of sudden death in Wolff-Parkinson-White syndrome<br />

Bloqueo de la vía anómala<br />

Con 50 mgs de Ajmalina<br />

Fananapazir L, Packer DL, German LD, et al. Procainamide infusion test: inability to identify patients with<br />

Wolff-Parkinson-White syndrome who are potentially at risk of sudden death. Circulation. 1988;77:1291–1296


The Natural History of Asymptomatic <strong>WPW</strong><br />

Electrophysiology-Based Studies<br />

Authors Number<br />

of Patients<br />

EP Study SCD Follow-up (yrs)<br />

AVRT AF SPRR<br />

Klein (4) 29 yes 17% 31% 0 4.5 *<br />

Satoh (5) 34 yes 18% 3% 0 1.3<br />

Beckman (6) 15 yes 20% 13% 0 7.5<br />

Leitch (7) 75 yes 16% 31% 0 4.3 *<br />

Fukatani (8) 64 yes n/a n/a 0 6.6<br />

Brembilla-Perrot (9) 40 yes 7.5% 12.5% 0 1.8<br />

Berkman (10) 128 no 13.3 % Symp 0 18<br />

Soria (11) 78 no 2 5.7<br />

Munger (12) 53 no 21 % Symp 0 10.1<br />

Goudevenos (13) 77 no 4 % Symp 0 4.6<br />

Fitzsimmons (14) 187 no 15 % Symp 0 21.8<br />

J Am Coll Cardiol. 2003 Jan 15;41(2):245-8.


Usefulness of invasive electrophysiologic testing to stratify<br />

the risk of arrhythmic events in asymptomatic patients with<br />

Wolff-Parkinson-White pattern: results from a large<br />

prospective long-term follow-up study<br />

Pappone C, Santinelli V, Rosanio S, et al<br />

212 Pctes<br />

162 Pctes<br />

<strong>WPW</strong> Asintomáticos. EEF<br />

5 Años<br />

EEF: 33 Pctes<br />

115 No Induc 47 Ind<br />

18.2 % Sin Preexit<br />

30% Retrocond<br />

3.4% TSV (4 pctes.)<br />

21 TSV<br />

8 FA<br />

sintomáticos<br />

2 RCP<br />

1 MS<br />

J Am Coll Cardiol, 2003; 41:245-248


<strong>WPW</strong>: Historia natural<br />

FV: Primer síntoma:<br />

3/25 6/25 8/15<br />

Klein GJ, Bashore TM, Sellers TD, Pritchett EL, Smith WM, Gallagher JJ. Ventricular fibrillation in the Wolff-Parkinson-White syndrome . N Engl J Med.<br />

1979;301:1080–1085<br />

Montoya PT, Brugada P, Smeets J, et al. Ventricular fibrillation in the Wolff-Parkinson-White syndrome. Eur Heart J. 1991;12:144–150<br />

Timmermans C, Smeets JL, Rodriguez LM, Vrouchos G, van den Dool A, Wellens HJ. Aborted sudden death in the Wolff-Parkinson-White syndrome.<br />

Am J Cardiol. 1995;76:492–494<br />

< 30 años


Complications of Radiofrequency Ablation<br />

Studies No. of<br />

Patients<br />

MERFS<br />

(24)<br />

NASPE<br />

(25)<br />

Comp<br />

Rate<br />

2,222 98<br />

(4.4%)<br />

5,427 99<br />

(1.8%)<br />

Perforation<br />

/<br />

Tamponade<br />

Complete<br />

AV Block<br />

MI CVA Death<br />

16 14 0 11 3<br />

4.4% 0.72% 0.63% 0 0.49<br />

%<br />

7 9 3 8 4<br />

1.8% 0.13% 0.17% 0.06% 0.15<br />

%<br />

Atakr (26) 500 n/a n/a 5 n/a 1 1<br />

0.13%<br />

0.07%<br />

1% 0.2% 0.2%<br />

AV = atrioventricular; CVA = cerebrovascular accident; Comp = complication; MERFS = Multicentre European<br />

Radiofrequency Survey; MI = myocardial infarction; n/a = not available; NASPE = North American Society of<br />

Pacing and Electrophysiology<br />

J Am Coll Cardiol. 2003 Jan 15;41(2):245-8


SI<br />

Preexitación<br />

Ablación<br />

Síntomas<br />

ventricular<br />

SI<br />

NO<br />

Alto Riesgo<br />

NO<br />

“Profesión” de riesgo<br />

SI NO<br />

Seguimiento


Preexitación<br />

NO<br />

ventricular<br />

Asintomático<br />

Ablación<br />

ParaHisiana<br />

SI<br />

SI<br />

Alto Riesgo<br />

NO<br />

“Profesión” de riesgo<br />

SI NO<br />

Seguimiento

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!